While the FDA is streamlining regulation of copycat versions of the expensive drugs that millions take for arthritis, cancer, and other diseases, the U.S. patent office is making it harder for the cheaper medicines to […]
They’re cute, even cuddly, and promise learning and companionship—but artificial intelligence toys are not safe for kids, according to children’s and consumer advocacy groups urging parents not to buy them during the holiday season.This article […]
Our brain’s reward system processes and reinforces pleasurable experiences, motivating us to seek out and engage in rewarding activities ranging from eating to social interactions to recreational drug use. Dopamine plays an important role in […]
People with type 1 diabetes (previously called juvenile diabetes) are 4.29 times more likely to develop bladder cancer, according to a systematic review and meta-analysis by researchers at the Keck School of Medicine of USC. […]
A compound that enables the delivery of insulin through the skin has been demonstrated in mice and minipigs. The findings, reported in a paper published in Nature, suggest a potential alternative to injection for diabetes […]
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline such as memory loss and behavioral disturbances that severely impair quality of life. Despite decades of research, effective disease-modifying therapies remain elusive, underscoring […]
Around two-thirds (68%) of pregnancies have weight gain that is more or less than recommended and that is associated with complications such as preterm birth, large birth weight, and admission to intensive care, finds a […]
Young people who play video games with “gambling-like” elements—such as buying loot boxes or in-game items—are more likely to go on to gamble with real money.This article was originally published on MedicalXpress.com
People paying out of pocket for Ozempic or Wegovy may soon see lower costs, as Novo Nordisk rolls out new price discounts for its popular GLP-1 medications.This article was originally published on MedicalXpress.com
Public interest in drugs known as glucagon-like peptide-1 receptor agonists, also called GLP-1 RAs, has surged in recent years, with popular types like semaglutide (sold under brand names like Ozempic and Wegovy) becoming known for […]
© 2025 SimplyWell.ca